Repare Therapeutics Inc. (RPTX) has 69 open-market insider trades by 19 insiders since 2020. The most active filer is Ansbert Gadicke, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ansbert Gadicke | 10% Owner | — | 14 | $55.6M | 2021-07-12 |
| BVF II GP LLC | 10% Owner | — | 1 | $43.7M | 2022-06-06 |
| Todd Foley | Dir | — | 14 | $37.4M | 2021-07-12 |
| Biotechnology VALUE FUND II L.P. | 10% Owner | — | 2 | $31.9M | 2022-06-13 |
| Davis Jerel | Dir | — | 3 | $24.3M | 2022-12-29 |
| David P. Bonita | Dir | — | 6 | $18.8M | 2021-09-07 |
| Biotechnology Value Trading Fund OS LP via Matthew D. Perry | 10% Owner | — | 2 | $13.5M | 2023-11-16 |
| Michael Zinda | CSOVP | — | 8 | $8.8M | 2025-03-12 |
| Versant Vantage I, L.P. | 10% Owner | — | 1 | $6.1M | 2022-06-06 |
| Versant Venture Capital V, L.P. | 10% Owner | — | 1 | $6.1M | 2022-06-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lloyd Mitchell Segal | President | Sell | $24K | 2025-03-12 |
| Maria Koehler | EVP & CHIEF MEDICAL OFFICER | Sell | $4K | 2025-03-12 |
| Steve Forte | CFO & EVP | Sell | $8K | 2025-03-12 |
| Michael Zinda | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $6K | 2025-03-12 |
| Maria Koehler | EVP & CHIEF MEDICAL OFFICER | Sell | $4K | 2024-03-28 |
| Steve Forte | CFO & EVP | Sell | $7K |
Companies that share insiders with RPTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-03-28 |
| Michael Zinda | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $4K | 2024-03-28 |
| Lloyd Mitchell Segal | President | Sell | $24K | 2024-03-28 |
| Maria Koehler | EVP & CHIEF MEDICAL OFFICER | Sell | $7K | 2024-03-25 |
| Michael Zinda | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $6K | 2024-03-25 |
| Steve Forte | CFO & EVP | Sell | $12K | 2024-03-25 |
| Lloyd Mitchell Segal | President | Sell | $37K | 2024-03-25 |
| Biotechnology Value Trading Fund OS LP | 10% Owner | Buy | $7.8M | 2023-11-15 |
| Biotechnology Value Trading Fund OS LP | 10% Owner | Buy | $5.6M | 2023-11-02 |
| Michael Zinda | CSO & VP | Sell | $189K | 2023-06-07 |